Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis
This report elaborates on the current development of the Purpura Therapy Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Shire Plc
KM Biologics
Novartis AG
Grifols Biologicals Inc
Ablynx NV
Pfizer Inc
Hovione
Amgen Inc
GlaxoSmithKline Plc
Lee's Pharmaceutical Holdings Ltd
Hoffman-L Roche
Omeros Corp
Bristol-Myers Squibb Company
By Type:
Allergic Purpura
Thrombocytopenic Purpura
By Application:
Hospital Use
Household
Clinic Use
Other
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Purpura Therapy Drugs Market Overview 2018-2029
-
1.1 China Purpura Therapy Drugs Industry Development Overview
-
1.2 China Purpura Therapy Drugs Industry Development History
-
1.3 China Purpura Therapy Drugs Industry Market Size (2018-2029)
-
1.4 China Purpura Therapy Drugs Market Analysis by Type from Production Side
-
1.4.1 China Purpura Therapy Drugs Production Volume, Production Value and Growth Rate of Allergic Purpura (2018-2029)
-
1.4.2 China Purpura Therapy Drugs Production Volume, Production Value and Growth Rate of Thrombocytopenic Purpura (2018-2029)
-
1.5 China Purpura Therapy Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Hospital Use (2018-2029)
-
1.5.2 China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Household (2018-2029)
-
1.5.3 China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Clinic Use (2018-2029)
-
1.5.4 China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.6 China Purpura Therapy Drugs Market Analysis by Region
-
1.6.1 North China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Purpura Therapy Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Purpura Therapy Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Purpura Therapy Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Purpura Therapy Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Purpura Therapy Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Purpura Therapy Drugs Industry Development
Chapter 3 Purpura Therapy DrugsIndustry Chain Analysis
-
3.1 Purpura Therapy Drugs Industry Chain
-
3.2 Purpura Therapy Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Purpura Therapy Drugs Market
-
3.3 Purpura Therapy Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Purpura Therapy Drugs Market
Chapter 4 China Purpura Therapy Drugs Market, by Type
-
4.1 China Purpura Therapy Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Purpura Therapy Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Purpura Therapy Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Purpura Therapy Drugs Production Volume and Growth Rate of Allergic Purpura
-
4.5.2 China Purpura Therapy Drugs Production Volume and Growth Rate of Thrombocytopenic Purpura
Chapter 5 China Purpura Therapy Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Purpura Therapy Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Purpura Therapy Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Purpura Therapy Drugs Market Size and Growth Rate of Hospital Use
-
5.5.2 China Purpura Therapy Drugs Market Size and Growth Rate of Household
-
5.5.3 China Purpura Therapy Drugs Market Size and Growth Rate of Clinic Use
-
5.5.4 China Purpura Therapy Drugs Market Size and Growth Rate of Other
Chapter 6 China Purpura Therapy Drugs Market, by Region
-
6.1 China Purpura Therapy Drugs Production Volume and Production Value, by Region
-
6.2 China Purpura Therapy Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Purpura Therapy Drugs Market Analysis
-
7.1 North China Purpura Therapy Drugs Market, by Type
-
7.2 North China Purpura Therapy Drugs Market, by Application
Chapter 8 Central China Purpura Therapy Drugs Market Analysis
-
8.1 Central China Purpura Therapy Drugs Market, by Type
-
8.2 Central China Purpura Therapy Drugs Market, by Application
Chapter 9 South China Purpura Therapy Drugs Market Analysis
-
9.1 South China Purpura Therapy Drugs Market, by Type
-
9.2 South China Purpura Therapy Drugs Market, by Application
Chapter 10 East China Purpura Therapy Drugs Market Analysis
-
10.1 East China Purpura Therapy Drugs Market, by Type
-
10.2 East China Purpura Therapy Drugs Market, by Application
Chapter 11 Northeast China Purpura Therapy Drugs Market Analysis
-
11.1 Northeast China Purpura Therapy Drugs Market, by Type
-
11.2 Northeast China Purpura Therapy Drugs Market, by Application
Chapter 12 Southwest China Purpura Therapy Drugs Market Analysis
-
12.1 Southwest China Purpura Therapy Drugs Market, by Type
-
12.2 Southwest China Purpura Therapy Drugs Market, by Application
Chapter 13 Northwest China Purpura Therapy Drugs Market Analysis
-
13.1 Northwest China Purpura Therapy Drugs Market, by Type
-
13.2 Northwest China Purpura Therapy Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Shire Plc
-
14.1.1 Shire Plc Company Profile
-
14.1.2 Shire Plc Purpura Therapy Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 KM Biologics
-
14.2.1 KM Biologics Company Profile
-
14.2.2 KM Biologics Purpura Therapy Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Profile
-
14.3.2 Novartis AG Purpura Therapy Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Grifols Biologicals Inc
-
14.4.1 Grifols Biologicals Inc Company Profile
-
14.4.2 Grifols Biologicals Inc Purpura Therapy Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Ablynx NV
-
14.5.1 Ablynx NV Company Profile
-
14.5.2 Ablynx NV Purpura Therapy Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Pfizer Inc
-
14.6.1 Pfizer Inc Company Profile
-
14.6.2 Pfizer Inc Purpura Therapy Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Hovione
-
14.7.1 Hovione Company Profile
-
14.7.2 Hovione Purpura Therapy Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Amgen Inc
-
14.8.1 Amgen Inc Company Profile
-
14.8.2 Amgen Inc Purpura Therapy Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 GlaxoSmithKline Plc
-
14.9.1 GlaxoSmithKline Plc Company Profile
-
14.9.2 GlaxoSmithKline Plc Purpura Therapy Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Lee's Pharmaceutical Holdings Ltd
-
14.10.1 Lee's Pharmaceutical Holdings Ltd Company Profile
-
14.10.2 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Hoffman-L Roche
-
14.11.1 Hoffman-L Roche Company Profile
-
14.11.2 Hoffman-L Roche Purpura Therapy Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Omeros Corp
-
14.12.1 Omeros Corp Company Profile
-
14.12.2 Omeros Corp Purpura Therapy Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Bristol-Myers Squibb Company
-
14.13.1 Bristol-Myers Squibb Company Company Profile
-
14.13.2 Bristol-Myers Squibb Company Purpura Therapy Drugs Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Purpura Therapy Drugs Industry Research Conclusions
-
15.2 Purpura Therapy Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Purpura Therapy Drugs Industry Market Size (2018-2029)
-
Figure China Purpura Therapy Drugs Production Volume, Production Value and Growth Rate of Allergic Purpura (2018-2029)
-
Figure China Purpura Therapy Drugs Production Volume, Production Value and Growth Rate of Thrombocytopenic Purpura (2018-2029)
-
Figure China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Hospital Use (2018-2029)
-
Figure China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Household (2018-2029)
-
Figure China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Clinic Use (2018-2029)
-
Figure China Purpura Therapy Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure North China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Purpura Therapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Purpura Therapy Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Purpura Therapy Drugs Market Share by Type in 2018
-
Figure China Purpura Therapy Drugs Market Share by Type in 2023
-
Figure China Purpura Therapy Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Purpura Therapy Drugs Production Volume and Growth Rate of Allergic Purpura (2018-2023)
-
Figure China Purpura Therapy Drugs Production Volume and Growth Rate of Thrombocytopenic Purpura (2018-2023)
-
Figure China Purpura Therapy Drugs Market Share by Application in 2018
-
Figure China Purpura Therapy Drugs Market Share by Application in 2023
-
Figure China Purpura Therapy Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Purpura Therapy Drugs Market Size and Growth Rate of Hospital Use (2018-2023)
-
Figure China Purpura Therapy Drugs Market Size and Growth Rate of Household (2018-2023)
-
Figure China Purpura Therapy Drugs Market Size and Growth Rate of Clinic Use (2018-2023)
-
Figure China Purpura Therapy Drugs Market Size and Growth Rate of Other (2018-2023)
-
Table China Purpura Therapy Drugs Production Volume by Region (2018-2023)
-
Table China Purpura Therapy Drugs Production Volume Share by Region (2018-2023)
-
Figure China Purpura Therapy Drugs Production Volume Share by Region (2018-2023)
-
Table China Purpura Therapy Drugs Production Value by Region (2018-2023)
-
Table China Purpura Therapy Drugs Production Value Share by Region (2018-2023)
-
Figure China Purpura Therapy Drugs Production Value Share by Region (2018-2023)
-
Table China Purpura Therapy Drugs Sales Volume by Region (2018-2023)
-
Table China Purpura Therapy Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Purpura Therapy Drugs Sales Volume Share by Region (2018-2023)
-
Table China Purpura Therapy Drugs Sales Value by Region (2018-2023)
-
Table China Purpura Therapy Drugs Sales Value Share by Region (2018-2023)
-
Figure China Purpura Therapy Drugs Sales Value Share by Region (2018-2023)
-
Table North China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table North China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table North China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table North China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table Central China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Central China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table South China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table South China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table South China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table East China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table East China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table East China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Purpura Therapy Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Purpura Therapy Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Purpura Therapy Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Purpura Therapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Shire Plc Company Profile
-
Table Shire Plc Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table KM Biologics Company Profile
-
Table KM Biologics Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Grifols Biologicals Inc Company Profile
-
Table Grifols Biologicals Inc Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Ablynx NV Company Profile
-
Table Ablynx NV Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Hovione Company Profile
-
Table Hovione Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Plc Company Profile
-
Table GlaxoSmithKline Plc Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Lee's Pharmaceutical Holdings Ltd Company Profile
-
Table Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Hoffman-L Roche Company Profile
-
Table Hoffman-L Roche Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Omeros Corp Company Profile
-
Table Omeros Corp Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Purpura Therapy Drugs Revenue, Price and Gross (2018-2023)
-
